Literature DB >> 32892760

Prevention of psychosis: moving on from the at-risk mental state to universal primary prevention.

Robin M Murray1,2, Anthony S David3, Olesya Ajnakina4.   

Abstract

The value of services for those with the 'At Risk Mental State for Psychosis' (ARMS) continues to be disputed. ARMS services have provided a valuable stimulus to academic research into the transition into psychosis. Furthermore, there is currently a welcome trend to transform such clinics into youth mental health services catering for the broader clientele of young people suffering from anxiety and depression, who already constitute the bulk of those seen at ARMS clinics. However, such services are never likely to make major inroads into preventing psychosis because they only reach a small proportion of those at risk. Evidence from medicine shows that avoiding exposure to factors which increase the risk of disease (e.g. poor nutrition, transmission of infection, tobacco smoking), produces greater public benefit than focussing efforts on individuals with, or about to develop, disease. We consider that the most productive approach for psychosis prevention is avoiding exposure to risk-increasing factors. The best-established risk factors for psychosis are obstetric events, childhood abuse, migration, city living, adverse life events and cannabis use. Some as city living, are likely proxies for an unknown causal factor(s) while preventing others such as childhood abuse is currently beyond our powers. The risk factor for psychosis which is most readily open to this approach is the use of cannabis. Therefore, as an initial step towards a strategy for universal primary prevention, we advocate public health campaigns to educate young people about the harms of regular use of high potency cannabis.

Entities:  

Keywords:  At-risk mental state; pathways to care; prevention; psychosis; schizophrenia; transition

Mesh:

Year:  2020        PMID: 32892760      PMCID: PMC7893507          DOI: 10.1017/S003329172000313X

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  44 in total

Review 1.  The prevention of schizophrenia.

Authors:  Alan S Brown; John J McGrath
Journal:  Schizophr Bull       Date:  2010-10-27       Impact factor: 9.306

2.  Does early intervention prevent chronic psychosis? A question for the Victorian Royal Commission into Mental Health.

Authors:  Stephen Allison; Tarun Bastiampillai; Gin S Malhi; David Castle
Journal:  Aust N Z J Psychiatry       Date:  2019-09-05       Impact factor: 5.744

3.  The promotion of health through planned sociopolitical change: challenges for research and policy.

Authors:  J B McKinlay
Journal:  Soc Sci Med       Date:  1993-01       Impact factor: 4.634

Review 4.  Social capital and psychosis: a scoping review.

Authors:  Martin Rotenberg; Kelly K Anderson; Kwame McKenzie
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2019-12-04       Impact factor: 4.328

5.  Trends in cannabis use prior to first presentation with schizophrenia, in South-East London between 1965 and 1999.

Authors:  J Boydell; J van Os; A Caspi; N Kennedy; E Giouroukou; P Fearon; M Farrell; R M Murray
Journal:  Psychol Med       Date:  2006-07-20       Impact factor: 7.723

6.  Annual incidence of cannabis-induced psychosis, other substance-induced psychoses and dually diagnosed schizophrenia and cannabis use disorder in Denmark from 1994 to 2016.

Authors:  Carsten Hjorthøj; Maria Oku Larsen; Marie Stefanie Kejser Starzer; Merete Nordentoft
Journal:  Psychol Med       Date:  2019-12-16       Impact factor: 7.723

7.  Insight in individuals with an At Risk Mental State.

Authors:  Julia M Lappin; Kevin D Morgan; Lucia R Valmaggia; Matthew R Broome; James B Woolley; Louise C Johns; Paul Tabraham; Elvira Bramon; Philip K McGuire
Journal:  Schizophr Res       Date:  2007-01-09       Impact factor: 4.939

Review 8.  Meta-analysis of the Association Between the Level of Cannabis Use and Risk of Psychosis.

Authors:  Arianna Marconi; Marta Di Forti; Cathryn M Lewis; Robin M Murray; Evangelos Vassos
Journal:  Schizophr Bull       Date:  2016-02-15       Impact factor: 9.306

9.  Treated Incidence of Psychotic Disorders in the Multinational EU-GEI Study.

Authors:  Hannah E Jongsma; Charlotte Gayer-Anderson; Antonio Lasalvia; Diego Quattrone; Alice Mulè; Andrei Szöke; Jean-Paul Selten; Caitlin Turner; Celso Arango; Ilaria Tarricone; Domenico Berardi; Andrea Tortelli; Pierre-Michel Llorca; Lieuwe de Haan; Julio Bobes; Miguel Bernardo; Julio Sanjuán; José Luis Santos; Manuel Arrojo; Cristina Marta Del-Ben; Paulo Rossi Menezes; Eva Velthorst; Robin M Murray; Bart P Rutten; Peter B Jones; Jim van Os; Craig Morgan; James B Kirkbride
Journal:  JAMA Psychiatry       Date:  2018-01-01       Impact factor: 21.596

Review 10.  Non-Genetic Factors in Schizophrenia.

Authors:  Simona A Stilo; Robin M Murray
Journal:  Curr Psychiatry Rep       Date:  2019-09-14       Impact factor: 5.285

View more
  1 in total

1.  Public health primary prevention implemented by clinical high-risk services for psychosis.

Authors:  Andrés Estradé; Gonzalo Salazar de Pablo; Alice Zanotti; Scott Wood; Helen L Fisher; Paolo Fusar-Poli
Journal:  Transl Psychiatry       Date:  2022-01-28       Impact factor: 7.989

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.